MCE Conferences Cardiology and Endocrinology for Primary Care Sep 25, 2026 – Sep 27, 2026

This MCE review connects common endocrine problems with the cardiovascular decisions that often accompany them in primary care. Diabetes, insulin therapy, obesity and lipid management are covered alongside valve disease, heart failure and atrial fibrillation. Other sessions focus on thyroid dysfunction, endocrine incidentalomas, ECG interpretation and choosing cardiovascular imaging. The original September 25–27, 2026 meeting at Samoset Resort On The Ocean in Maine was designed for physicians and other health professionals seeking practical updates across these two specialties. Its learning objectives and daily topics are retained below, including the program’s emphasis on assessment, treatment and referral decisions.

Package scope: The agenda describes the original educational program and does not establish a complete manifest of delivered files. Live participation, workshops, faculty interaction and publisher account access are not included.

Learning Objectives

Upon completion of this program, participants should be better able to:

• Review prediabetes, lifestyle, and non-insulin medical therapy for type 2 diabetes.
• Safely initiate insulin therapy in patients with type 2 diabetes and implement intensive insulin regimens for the management of type 1 diabetes.
• Review the basic pathophysiology of aortic stenosis, apply newer concepts in the timing of valve replacement, role of stress testing, and biomarkers, and discuss transcatheter aortic valve intervention (TAVI/TAVR) indications and referrals compared with surgical AVR.
• Review the basic pathophysiology of mitral regurgitation, discuss the timing of mitral valve surgical intervention in asymptomatic patients with severe MR, and evaluate emerging catheter-based therapies.
• Identify common ECG presentations of cardiac conditions and apply interpretation pearls in clinical practice.
• Review the diagnosis, common causes of exacerbation, lifestyle modification, and pharmacological management of congestive heart failure with a specific focus on the geriatric population.
• Assess patients with obesity and discuss comprehensive weight loss options, including lifestyle interventions and anti-obesity medical therapy.
• Apply current cholesterol guidelines for LDL-lowering in primary and secondary prevention, and manage statin intolerance, hypertriglyceridemia, and elevated lipoprotein(a).
• Perform appropriate workups and management for endocrine incidentalomas, including adrenal masses, pituitary masses, and thyroid nodules.
• Formulate diagnostic workups and clinical management strategies for disorders of thyroid function, including hypothyroidism and hyperthyroidism.
• Evaluate thromboembolic risk, discuss asymptomatic and device-detected atrial fibrillation, and select appropriate direct oral anticoagulation options.
• Apply contemporary cardiovascular imaging, including coronary CT, cardiac MRI, stress testing, and nuclear imaging, in frontline clinical scenarios while recognizing key advantages and pitfalls.

Topics

• Friday, September 25th

  • Update on the Management of Type 2 Diabetes

  • Insulin Therapy in Diabetes

  • Aortic Stenosis: An Old Disease with New Treatment Options

  • Mitral Regurgitation

• Saturday, September 26th

  • Interactive EKG Refresher

  • Office Management of Heart Failure: Focus on the Geriatric Population

  • Management of Obesity

  • An Update on the Management of Lipid Disorders

• Sunday, September 27th

  • Endocrine Incidentalomas (Adrenal Masses, Pituitary Masses, and Thyroid Nodules)

  • Disorders of Thyroid Function (Hypothyroidism and Hyperthyroidism)

  • Atrial Fibrillation: Practical Management, Monitoring, and Anticoagulation Options

  • Case-Based Cardiology Imaging Refresher for the Frontline Clinician (Coronary CT, Cardiac MRI, Stress Testing, and Nuclear Imaging)